Banner for leaf pages 2

Ticagrelor (Brilinta)

Also known as Brilinta

Ticagrelor (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed ticagrelor to treat rabies, blastomycosis, west nile virus, and pick disease.

What drug interactions are known?

Do not take ticagrelor if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...